𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study

✍ Scribed by Bernard L. Zidar; Barbara Metch; Stanley P. Balcerzak; H. Irving Pierce; Liboria Militello; Michael D. Keppen; Jeffrey L. Berenberg

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
531 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High-dose ifosfamide with mesna and gran
High-dose ifosfamide with mesna and granuloctye–colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma : A Southwest Oncology Group study
✍ Susan M. Talbot; Cathryn Rankin; Robert N. Taub; Stanley P. Balcerzak Jr.; Nirma πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract ## BACKGROUND The current study was conducted to assess the activity and toxicity of high‐dose ifosfamide and mesna with recombinant human granulocyte–colony‐stimulating factor (rhG‐CSF), given in an outpatient setting, in the treatment of patients with unresectable malignant mesotheli

Phase II evaluation of bleomycin. A Sout
Phase II evaluation of bleomycin. A Southwest Oncology Group study
✍ Charles D. Haas; Charles A. Coltman Jr.; Jeffrey A. Gottlieb; Arthur Haut; James πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 369 KB πŸ‘ 2 views

Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and

Phase II evaluation of galactitol in hea
Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study
✍ Haas, Charles D. ;Lehane, Daniel ;Bottomley, Richard πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No dru

A southwest oncology group and cancer an
A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma
✍ Karen Antman; John Crowley; Stanley P. Balcerzak; Raymond A. Kempf; Raymond B. W πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

sarcoma, or osteosarcoma. ## Results . Between 1987-1991, 81 patients were entered; 69 patients were eligible.